Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
220M
-
Shares change
-
-19.3M
-
Total reported value, excl. options
-
$379M
-
Value change
-
-$104M
-
Put/Call ratio
-
1.01
-
Number of buys
-
126
-
Number of sells
-
-151
-
Price
-
$1.72
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2025
335 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2025.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 220M shares
of 334M outstanding shares and own 65.82% of the company stock.
Largest 10 shareholders include MHR FUND MANAGEMENT LLC (29M shares), VANGUARD GROUP INC (25.1M shares), BlackRock, Inc. (23.2M shares), Long Focus Capital Management, LLC (11.8M shares), STATE STREET CORP (9.89M shares), MILLENNIUM MANAGEMENT LLC (9.33M shares), Invenomic Capital Management LP (8.29M shares), MORGAN STANLEY (6.45M shares), GEODE CAPITAL MANAGEMENT, LLC (6.19M shares), and RENAISSANCE TECHNOLOGIES LLC (4.89M shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.